B3galt5 is also responsible for the galactosylation of GlcNAc-based acceptors and glycosphingolipids (GSLs), which are known to be involved in the pathogenesis of insulin resistance in type 2 diabetes39,40. Here, B3GALT5 is linked to Insulin resistance.